Rivfloza® (nedosiran) injection 80 mg, 128 mg, or 160 mg is indicated to lower urinary oxalate levels in children 9 years of age and older and adults with primary hyperoxaluria type 1 (PH1) and relatively preserved kidney function, eg, eGFR ≥30 mL/min/1.73 m2.
Savings and support for your patients
Novo Nordisk is committed to helping you support your appropriate patients with primary hyperoxaluria type 1 (PH1) throughout their treatment. NovoCare® offers benefits verification, a savings offer, support with prior authorization submission, and more for Rivfloza® (nedosiran) injection.
Need assistance now? Call 1‑844‑906‑5099, 8:00 am‑8:00 pm ET, Monday‑Friday.
Savings and support for your patients
Novo Nordisk is committed to helping you support your appropriate patients with primary hyperoxaluria type 1 (PH1) throughout their treatment. NovoCare® offers benefits verification, a savings offer, support with prior authorization submission, and more for Rivfloza® (nedosiran) injection.
Need assistance now? Call 1‑844‑906‑5099, 8:00 am‑8:00 pm ET, Monday‑Friday.
Start with the Patient Enrollment Form (PEF)
Use this form to enroll your patient in the NovoCare® Program and verify their insurance benefits.
You can also use the PEF to request any of the following: starter kit, JumpStart™, NovoCare® Savings Offer, and injection training.
Two ways to submit the PEF
To submit online, complete the required fields and sign electronically.
To submit offline, download the form and fax the completed form to 1‑866‑488‑6576.
What to expect after submitting
Once you have submitted the form, you can expect to be contacted by a NovoCare® Case Manager within 48 hours, Monday-Friday.a
A Patient Liaison will reach out to your patient to complete their portion of the enrollment and welcome them to the program.
aA Case Manager will respond within 48 business hours, Monday-Friday, 8 a.m. to 8 p.m. Inaccurate or missing information in your form could delay patient enrollment.
Ready. Set. Start.
The Patient Starter Kit contains support materials to help patients initiate therapy.
Provided exclusively through NovoCare® upon request.
Request a starter kit for your patient on the Patient Enrollment form, or call 1‑844‑906‑5099.
Prior authorizations (PAs) and appeals
We will provide information about payer requirements for the PA process and can help with the submission of supporting documents.
If initial insurance claims are denied, NovoCare® can provide assistance for eligible patients through the appeals process.
Call 1‑844‑906‑5099.
Help patients save
If your patients have commercial insurance, such as insurance they receive through an employer, they may be eligible to pay as little as $0 per fill of Rivfloza® (with an annual maximum cap of $15,000).
Direct your patient to RivflozaSavings.com to sign up for the savings offer.
Our commitment to affordability
NovoCare® has programs to help your patients afford their medication.
JumpStart™: Patients experiencing a gap or delay in insurance coverage may be eligible for a limited supply of free medication.
Patient Assistance Program (PAP): Patients who do not have adequate insurance coverage may be eligible for free medication.
To learn more about these programs or for eligibility and restrictions, call NovoCare® at 1‑844‑906‑5099.
Resources for patients
Simplify health insurance for patients
We can help patients make sense of the often complicated health insurance landscape. From copays to formularies, we explain the basics and provide helpful tips and resources, including ones specifically for people taking Novo Nordisk medications.
Refer your patients to PH1.HealthInsuranceEd.com
Support resources outside of Novo Nordisk
Novo Nordisk is committed to helping patients with primary hyperoxaluria type 1 (PH1). Our partners can help, too. We've gathered a collection of public resources that can help inform your patients.